Viraday
Viraday 30tabs Efavirenz + Emtricitabine + Tenofovir

Viraday 30tabs Efavirenz + Emtricitabine + Tenofovir

$163.13

Each Viraday contains efavirenz, emtricitabine and tenofovir 30 tablets and is is used to treat HIV infection and to treat hepatitis B infection.

ATC Classification: J05AF07
Active Ingrediant: Tenofovir Disoproxil Fumarate
Generic Name: Viraday
Manufacturer: Cipla Limited
Strength: 600/200/300mg
Dosage Type: Tablet
Packaging Type: Bottle in Box
Contains: 30 Tabs

Description

Tenofovir Disoproxil Fumarate Information

Pronunciation

ten OF oh vir dye soe PROX il FUE ma rate

 

What is this drug used for?

• It is used to treat HIV infection.

• It is used to treat hepatitis B infection.

Frequently reported side effects of this drug

• Headache

• Dizziness

• Nausea

• Vomiting

• Diarrhea

• Pain

• Abdominal pain

• Trouble sleeping

• Anxiety

• Loss of strength and energy

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Liver problems like dark urine, fatigue, lack of appetite, nausea, abdominal pain, light-colored stools, vomiting, or yellow skin.

• Kidney problems like unable to pass urine, blood in the urine, change in amount of urine passed, or weight gain.

• Lactic acidosis like fast breathing, fast heartbeat, abnormal heartbeat, vomiting, fatigue, shortness of breath, severe loss of strength and energy, severe dizziness, feeling cold, or muscle pain or cramps.

• Depression

• Bone pain

• Muscle pain

• Muscle weakness

• Painful extremities

• Burning or numbness feeling

• Infection

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

 

Medication Safety Issues

High alert medication:

This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes that have a heightened risk of causing significant patient harm when used in error.

 

Storage and Stability

Store at 25°C (77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F). Dispense only in original container.

 

Adverse Reactions

Includes data from both treatment-naive and treatment-experienced HIV patients and in chronic hepatitis B.

Cardiovascular: Chest pain

Central nervous system: Anxiety, depression, dizziness, fatigue, headache, insomnia, pain, peripheral neuropathy

Dermatologic: Diaphoresis, pruritus, skin rash (includes maculopapular, pustular, or vesiculobullous rash; pruritus; or urticaria)

Endocrine & metabolic: Glycosuria, hypercholesterolemia, hyperglycemia, increased serum triglycerides, lipodystrophy, weight loss

Gastrointestinal: Abdominal pain, anorexia, diarrhea, dyspepsia, flatulence, increased serum amylase, nausea, vomiting

Genitourinary: Hematuria

Hematologic & oncologic: Neutropenia

Hepatic: Increased serum alkaline phosphatase, increased serum ALT, increased serum AST, increased serum transaminases

Neuromuscular & skeletal: Arthralgia, back pain, decreased bone mineral density, increased creatine phosphokinase, myalgia, weakness

Renal: Increased serum creatinine, renal failure

Respiratory: Nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection

Miscellaneous: Fever

Brand

Cipla

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Shipping From